Brachytherapy Market Size, Share, Growth Analysis, By Technique(High Dose Rate (HDR), Low Dose Rate (LDR)), By Application(Gynecological Cancer, Prostate Cancer, Breast Cancer, Others), By End User(Hospitals, Specialty Clinics, Others), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35D2138 | Region: Global | Published Date: April, 2024
Pages: 219 |Tables: 90 |Figures: 78

Brachytherapy Market Insights

Brachytherapy Market size was valued at USD 539.61 Million in 2023 and is poised to grow from USD 582.24 Million in 2024 to USD 1069.72 Million by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The growth of the global brachytherapy market is expected to be driven by factors such as the increasing prevalence of cancer, advancements in technology, and a significant rise in the adoption of brachytherapy. Brachytherapy is a form of radiation therapy where radioactive materials are placed inside the body using catheters to treat cancer.

Brachytherapy is a highly effective treatment for localized tumors, utilizing artificially produced radionuclides such as Caesium-137, Iridium-192, Gold-198, Iodine-125, and Palladium-103. The International Agency for Research on Cancer (IARC) estimates that the global incidence of cancer is around 19.3 million and is projected to increase to 24.6 million by 2030.

This growing cancer burden is a major driver for the market. Radiation therapy can be used for various purposes, including prophylactic, palliative, or curative treatment, either as monotherapy or in combination with surgery, immunotherapy, or chemotherapy. The broad range of applications has led to increased adoption by physicians. Recent advancements in radiation therapy techniques enable the precise delivery of high doses to the target area while minimizing damage to surrounding healthy tissues. This has significantly improved localized tumor control and cure rates, thereby increasing the demand for radiation therapy.

US Brachytherapy Market is poised to grow at sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 500.1 Million

Largest Segment

HDR

Fastest Growth

HDR

Growth Rate

7.9% CAGR

Global Brachytherapy Market ($ Mn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Brachytherapy Market Segmental Analysis

Global Brachytherapy Market is segmented on the basis of technique, application, end user and region. By technique, the market is segmented into high dose rate (HDR), and low dose rate (LDR). By application, the market is segmented into prostate cancer, gynecological cancer, breast cancer, others. By end user, the market is segmented into hospitals, specialty clinics, and others. The brachytherapy market is analyzed across North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Brachytherapy Market Analysis by Application

By accounting for the biggest revenue share of 32.9% in 2023, the prostate cancer segment led the market. All individuals with localized prostate cancer can benefit from brachytherapy, which is a successful treatment option both alone and in combination with external beam radiation therapy. Brachytherapy's promising uses in the management of prostate cancer are what are propelling this market.

During the projected period, a CAGR of 7.6% is anticipated in the application category for breast cancer brachytherapy. The growing usage of brachytherapy in Accelerated Partial Breast Irradiation (APBI) is one of the main drivers behind the expansion of this industry. This market's expansion is also anticipated to be fueled by the increasing incidence of breast cancer.

Brachytherapy Market Analysis by Technique

With a market share of 71.2% in 2023, the HDR brachytherapy category led the industry. In most cases, the therapy is carried out as an outpatient operation to treat various cancers, including skin, cervical, prostate, head and neck, and breast cancer. Some of the elements influencing this segment's dominance are short procedure times, greater efficacy, and radiation protection. LDR after loaders are gradually being replaced with HDR after loaders all over the world because the maintenance of LDR systems is no longer typically guaranteed by the manufacturers.

Prostate cancer treatment is the main use of LDR brachytherapy. This market is anticipated to expand as a result of the release of novel products like GammaTile for the treatment of brain cancer. With Cesium-131 seeds, which have a superior adverse effect profile than other frequently used LDR isotopes, IsoRay was granted FDA 510K approval for this device.

Global Brachytherapy Market By Dosage Type

To get detailed analysis on other segments, Request For Free Sample Report

Brachytherapy Market Regional Insights

With a 45.7% revenue share in 2023, North America dominated the brachytherapy market. Due to the benefits, it provides over conventional methods—namely, that it is a relatively safer and effective cancer treatment—brachytherapy is commonly utilized in North America. In 2022, Europe represented a share of almost 25,0%. Over the past five years, brachytherapy use in the European region has grown.

The market in Asia Pacific is anticipated to see the greatest CAGR. The area is home to more than 60% of the world's population and carries half of the burden of cancer globally. As a result of an unhealthy lifestyle, cancer incidence is increasing. Additionally, the limited availability of technologically sophisticated cancer therapies presents numerous potentials for the market players.

Global Brachytherapy Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Brachytherapy Market Dynamics

Brachytherapy Market Drivers

Growing Demand For Minimally Invasive Procedures

  • Minimally invasive treatment procedures are preferred by patients due to reduced post-operative complications, shorter hospital stays, and faster recovery times. Brachytherapy is a minimally invasive treatment option that can be performed on an outpatient basis in many cases. The increasing demand for minimally invasive procedures contributes to the growth of the brachytherapy market.

Aging Population And Increasing Life Expectancy

  • The global aging population and increasing life expectancy are significant drivers for the brachytherapy market. Cancer incidence tends to be higher in older individuals, and brachytherapy is a viable treatment option, especially for localized tumors. The aging population, coupled with advancements in cancer screening and cancer diagnosis, drives the demand for brachytherapy procedures.

Brachytherapy Market Restraints

High Initial Setup And Equipment Costs

  • Brachytherapy requires specialized equipment and infrastructure for treatment planning, radiation delivery, and patient safety. The initial setup costs, including the purchase and installation of equipment, can be significant. This high upfront investment can act as a barrier for healthcare facilities, especially in resource-constrained regions, limiting the adoption of brachytherapy.

Request Free Customization of this report to help us to meet your business objectives.

Brachytherapy Market Competitive Landscape

The global brachytherapy market is highly competitive, with several key players competing for market share. These companies focus on developing advanced brachytherapy technologies, expanding their product portfolios, and expanding their presence in emerging markets.

Brachytherapy Market Top Player’s Company Profiles

  • IsoAid LLC (United States)
  • Theragenics Corporation (United States)
  • C. R. Bard, Inc. (United States)
  • Boston Scientific Corporation (United States)
  • Isoray Inc. (United States)
  • Nucletron B.V. (Netherlands)
  • Huiheng Medical, Inc. (China)
  • iCAD, Inc. (United States)
  • Elekta AB (Sweden)
  • Nanobiotix SA (France)
  • BTG International Ltd. (United Kingdom)
  • GE Healthcare (United States)
  • IBA Worldwide (Belgium)
  • Cianna Medical, Inc. (United States)
  • Theragenics Corporation (United States)
  • C4 Imaging LLC (United States)
  • CIVCO Medical Solutions (United States)
  • RaySearch Laboratories AB (Sweden)
  • Hologic, Inc. (United States)

Brachytherapy Market Recent Developments

  • In May 2023, Varian Medical Systems announced the launch of its new brachytherapy system, the TrueBeam STx. The TrueBeam STx is a high-dose rate (HDR) brachytherapy system that uses a linear accelerator to deliver high doses of radiation to tumors.
  • In April 2023, Elekta announced the acquisition of Calypso Medical, a company that develops and manufactures real-time tumor tracking systems for brachytherapy. The acquisition will allow Elekta to offer a more comprehensive brachytherapy solution to its customers.
  • In March 2023, the FDA approved the TomoTherapy Hi-Art brachytherapy system for the treatment of prostate cancer. The TomoTherapy Hi-Art system is a robotic brachytherapy system that uses a CT scanner to image the tumor and then delivers radiation to the tumor in a precise and targeted manner.

Brachytherapy Key Market Trends

  • Growing preference for organ-preserving treatments : Brachytherapy is often chosen as an organ-preserving treatment modality, particularly in cancers such as prostate, breast, and cervical cancer. It allows for targeted radiation delivery while minimizing damage to surrounding healthy tissues, thereby preserving organ function and improving quality of life for patients. The trend towards organ preservation and minimally invasive treatments has led to increased adoption of brachytherapy.

Brachytherapy Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analyses, the global brachytherapy market is a rapidly growing segment of the healthcare industry. Brachytherapy, a type of radiation therapy, involves the precise placement of radioactive sources within or near the tumor site to deliver targeted radiation treatment. It is widely used in the treatment of various types of cancers, including prostate, breast, cervical, and skin cancer, among others. The market for brachytherapy is driven by several factors. The increasing prevalence of cancer worldwide, coupled with the rising aging population, is a significant driver for the market. According to the International Agency for Research on Cancer (IARC), the global incidence of cancer is projected to increase, leading to a growing demand for effective treatment options such as brachytherapy. The increasing prevalence of cancer and the shift towards minimally invasive treatments are expected to drive the demand for brachytherapy in the coming years.

Report Metric Details
Market size value in 2022 USD 500.1 Million
Market size value in 2031 USD 991.4 Million
Growth Rate 7.9%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Technique
    • High Dose Rate (HDR), Low Dose Rate (LDR)
  • Application
    • Gynecological Cancer, Prostate Cancer, Breast Cancer, Others
  • End User
    • Hospitals, Specialty Clinics, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • IsoAid LLC (United States)
  • Theragenics Corporation (United States)
  • C. R. Bard, Inc. (United States)
  • Boston Scientific Corporation (United States)
  • Isoray Inc. (United States)
  • Nucletron B.V. (Netherlands)
  • Huiheng Medical, Inc. (China)
  • iCAD, Inc. (United States)
  • Elekta AB (Sweden)
  • Nanobiotix SA (France)
  • BTG International Ltd. (United Kingdom)
  • GE Healthcare (United States)
  • IBA Worldwide (Belgium)
  • Cianna Medical, Inc. (United States)
  • Theragenics Corporation (United States)
  • C4 Imaging LLC (United States)
  • CIVCO Medical Solutions (United States)
  • RaySearch Laboratories AB (Sweden)
  • Hologic, Inc. (United States)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Brachytherapy Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Brachytherapy Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Brachytherapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Brachytherapy Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Brachytherapy Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Brachytherapy Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Global Brachytherapy Market size was valued at USD 500.1 Million in 2022 and is poised to grow from USD 539.61 Million in 2023 to USD 991.4 Million by 2031, at a CAGR of 7.9% during the forecast period (2024-2031).

The global brachytherapy market is highly competitive, with several key players competing for market share. These companies focus on developing advanced brachytherapy technologies, expanding their product portfolios, and expanding their presence in emerging markets. 'Eckert & Ziegler BEBIG (Germany)', 'Varian Medical Systems, Inc. (United States)', 'Elekta AB (Sweden)', 'IsoAid LLC (United States)', 'Theragenics Corporation (United States)', 'C. R. Bard, Inc. (United States)', 'Boston Scientific Corporation (United States)', 'Isoray Inc. (United States)', 'Nucletron B.V. (Netherlands)', 'Huiheng Medical, Inc. (China)', 'iCAD, Inc. (United States)', 'Elekta AB (Sweden)', 'Nanobiotix SA (France)', 'BTG International Ltd. (United Kingdom)', 'GE Healthcare (United States)', 'IBA Worldwide (Belgium)', 'Cianna Medical, Inc. (United States)', 'Theragenics Corporation (United States)', 'C4 Imaging LLC (United States)', 'CIVCO Medical Solutions (United States)', 'RaySearch Laboratories AB (Sweden)', 'Hologic, Inc. (United States)'

Minimally invasive treatment procedures are preferred by patients due to reduced post-operative complications, shorter hospital stays, and faster recovery times. Brachytherapy is a minimally invasive treatment option that can be performed on an outpatient basis in many cases. The increasing demand for minimally invasive procedures contributes to the growth of the brachytherapy market.

Growing preference for organ-preserving treatments : Brachytherapy is often chosen as an organ-preserving treatment modality, particularly in cancers such as prostate, breast, and cervical cancer. It allows for targeted radiation delivery while minimizing damage to surrounding healthy tissues, thereby preserving organ function and improving quality of life for patients. The trend towards organ preservation and minimally invasive treatments has led to increased adoption of brachytherapy.

With a 45.7% revenue share in 2023, North America dominated the brachytherapy market. Due to the benefits, it provides over conventional methods—namely, that it is a relatively safer and effective cancer treatment—brachytherapy is commonly utilized in North America. In 2022, Europe represented a share of almost 25,0%. Over the past five years, brachytherapy use in the European region has grown.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Brachytherapy Market

Report ID: SQMIG35D2138

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE